DAVID C. STUMP - 31 May 2023 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Director
Signature
/s/ Lynn M. Cilinski, Attorney-in-fact
Issuer symbol
MGNX
Transactions as of
31 May 2023
Net transactions value
$0
Form type
4
Filing time
02 Jun 2023, 16:54:46 UTC
Previous filing
07 Jun 2022
Next filing
06 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Stock Option (right to buy) Award $0 +19,000 $0.000000 19,000 31 May 2023 Common Stock 19,000 $4.67 Direct F1
transaction MGNX Restricted Stock Unit Award $0 +4,500 $0.000000 4,500 31 May 2023 Common Stock 4,500 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.
F2 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer?s Common Stock. The RSU grant was approved by the Issuer?s Board of Directors on May 31, 2023 and will be effective as of the date the Issuer has an effective Registration Statement on Form S-8 registering the shares available for issuance under the 2023 Equity Incentive Plan.
F3 The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier